Beam Therapeutics Inc. is a US-based biotechnology company creating precise genetic medicines for patients with severe ailments. With BEAM-101, BEAM-102, BEAM-201, and BEAM-301, the organization aims to treat sickle cell disease and beta thalassemia, and other diseases of the liver, muscle, eyes, and nervous system. Beam Therapeutics collaborates with well-known organizations such as the Boston Children's Hospital, Pfizer, and Apellis Pharmaceuticals.